Finance

Lists
Why is OCEA up 33.33%?
Dive Deeper
OCEA:OTCMKTS
Ocean Biomedical Inc
$0.00040
+33.33%
(+0.000100) 1D
Nov 19, 4:00:00 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OCEA...
Open
$0.00
High
$0.00
Low
$0.00
Mkt. cap
64.13K
Avg. vol.
62.90K
Volume
0.00
52-wk high
$0.01
52-wk low
$0.00
Beta
2.77
Shares outstanding
232.36M
No. of employees
7
Open
$0.00
High
$0.00
Low
$0.00
Mkt. cap
64.13K
Avg. vol.
62.90K
Volume
0.00
52-wk high
$0.01
52-wk low
$0.00
Beta
2.77
Shares outstanding
232.36M
No. of employees
7
News stories
From web sources and news partners
Profile
Ocean Biomedical is a new-generation American biopharmaceutical company based in Providence, Rhode Island. The company has product candidates addressing malaria, pulmonary fibrosis, and lung cancer. Ocean Biomedical was founded by Indian-American physician Chirinjeev Kathuria with Scientific Co-founders Jack Elias and Dr. Jonathan Kurtis, both from Brown University’s Medical School faculty. They aim to build a pipeline of preclinical, clinical, and commercial drug development by bringing together interdisciplinary expertise and resources. Wikipedia
About Ocean Biomedical Inc
CEO-
Employees7
Founded2019
HeadquartersProvidence, Rhode Island, United States
SectorHealth Care
IndustryBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
18.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
768.00K
1.75M
940.00K
Operating expense
-
768.00K
1.75M
958.00K
Total operating expenses
-
768.00K
1.75M
958.00K
Operating income
-
-768.00K
-1.75M
-958.00K
Other non operating income
-
-3.82M
2.47M
-6.94M
EBT including unusual items
-
-5.53M
283.00K
-8.24M
EBT excluding unusual items
-
-5.53M
283.00K
-8.24M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-
-5.53M
283.00K
-8.24M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-461.00K
-433.00K
-343.00K
Net interest expenses
-
-461.00K
-433.00K
-343.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps